ArticleItalian journal of pediatrics2026
Clinical and laboratory features of pediatric Mycoplasma pneumoniae Pneumonia with viral versus bacterial co-infection.
Article in Italian journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectiveTo analyse the epidemiological, clinical, and laboratory differences among children, in Suzhou, with Mycoplasma pneumoniae (MP) mixed with viral or bacterial pneumonia and to provide evidence for early clinical differentiation and localised prevention.
methodsThis retrospective study included 392 children with Mycoplasma pneumoniae pneumonia (MPP) who were divided into an MPP mixed with viral pneumonia group (n = 254) and a bacterial pneumonia group (n = 138). Epidemiological characteristics, clinical manifestations, immune, coagulation, and inflammatory indicators, pathogen distribution, and bacterial drug susceptibility were compared.
resultsThe MPP mixed with viral pneumonia group had older children [6 (3, 8) vs. 4 (2, 6.25) years, P = 0.001], a higher incidence of pneumonia in spring (51.97% vs. 18.12%, P < 0.001), and more crackles and fewer breath sounds (P < 0.05). The MPP mixed with bacterial group was more common in the summer and autumn, with a higher vomiting incidence (P = 0.021), higher C3 abnormal rate (P = 0.049) and greater procalcitonin elevation (P < 0.001). The MPP mixed with viral pneumonia group had higher level of serum amyloid A and D-dimer (P < 0.05). Human rhinovirus was the predominant virus (53.67%), and Streptococcus pneumoniae was the main bacterium (58.99%) with 100% Erythromycin resistance but high sensitivity to Penicillin G and Cefotaxime.
conclusionsThe two groups differed in age, season, clinical features, and several biomarkers. Viral coinfection was associated with higher SAA and D-dimer, while bacterial coinfection with higher PCT. However, the discriminatory value of these markers is limited, and they should be used in conjunction with other clinical data. Local pathogens were dominated by rhinovirus and S. pneumoniae, with the latter exhibiting complete erythromycin resistance, highlighting the need for surveillance and rational antibiotic use.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.